Deregulated Intracellular Signaling by Mutated c-CBL in Myeloid NeoplasmsOGAWA, Seishi; SHIH, Lee-Yung; SUZUKI, Takahiro et al.Clinical cancer research (Print). 2010, Vol 16, Num 15, pp 3825-3831, issn 1078-0432, 7 p.Article

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesABDEL-WAHAB, Omar; MULLALLY, Ann; HUBERMAN, Kety et al.Blood. 2009, Vol 114, Num 1, pp 144-147, issn 0006-4971, 4 p.Article

The renaissance of interferon therapy for the treatment of myeloid malignanciesKILADJIAN, Jean-Jacques; MESA, Ruben A; HOFFMAN, Ronald et al.Blood. 2011, Vol 117, Num 18, pp 4706-4715, issn 0006-4971, 10 p.Article

Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies RevisitedJEREZ, Andres; GONDEK, Lukasz P; MCDEVITT, Michael A et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1343-1349, issn 0732-183X, 7 p.Article

The relevance of transfusion-dependency in the prognostic assessment of patients with myeloid neoplasmsMALCOVATI, Luca; CAZZOLA, Mario.American journal of hematology. 2011, Vol 86, Num 3, pp 241-243, issn 0361-8609, 3 p.Article

A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignanciesKIRITO, Keita; SAKOE, Kumi; SHINODA, Daisuke et al.Haematologica (Roma). 2008, Vol 93, Num 1, pp 155-156, issn 0390-6078, 2 p.Article

Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesPUDA, Ana; MILOSEVIC, Jelena D; DOUBEK, Michael et al.American journal of hematology. 2012, Vol 87, Num 3, pp 245-250, issn 0361-8609, 6 p.Article

Sole abnormalities of chromosome 7 in myeloid malignancies: Spectrum, histopathologic correlates, and prognostic implicationsFAREEDA TAHER NAZER HUSSAIN; NGUYEN, Edward P; RAZA, Sania et al.American journal of hematology. 2012, Vol 87, Num 7, pp 684-686, issn 0361-8609, 3 p.Article

Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignanciesPARDANANI, Animesh; LIM, Ken-Hong; LASHO, Terra L et al.Blood. 2009, Vol 114, Num 18, pp 3769-3772, issn 0006-4971, 4 p.Article

Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignanciesADELAÏDE, J; GELSI-BOYER, V; CHAFFANET, M et al.Leukemia. 2010, Vol 24, Num 8, pp 1539-1541, issn 0887-6924, 3 p.Article

Myeloid neoplasm with rearrangement of PDGFRA, but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity?RUDZKI, Zbigniew; GILES, Louise; CROSS, Nicholas C. P et al.British journal of haematology. 2012, Vol 156, Num 5, issn 0007-1048, p. 558Article

Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignanciesWONG, Jasmine C. Y; YAN ZHANG; LE BEAU, Michelle M et al.Blood. 2010, Vol 115, Num 22, pp 4524-4532, issn 0006-4971, 9 p.Article

Npml is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouseSPORTOLETTI, Paolo; GRISENDI, Silvia; MAJID, Samia M et al.Blood. 2008, Vol 111, Num 7, pp 3859-3862, issn 0006-4971, 4 p.Article

Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosisSTRATHDEE, Gordon; HOLYOAKE, Tessa L; JORGENSEN, Heather G et al.Clinical cancer research. 2007, Vol 13, Num 17, pp 5048-5055, issn 1078-0432, 8 p.Article

G-CSF and its receptor in myeloid malignancyBEEKMAN, Renée; TOUW, Ivo P.Blood. 2010, Vol 115, Num 25, pp 5131-5136, issn 0006-4971, 6 p.Article

Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of AgeKALES, Stephen C; RYAN, Philip E; NAU, Marion M et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 12, pp 4789-4794, issn 0008-5472, 6 p.Article

Trisomy 14 as a Sole Chromosome Abnormality Is Associated with Older Age, a Heterogenous Group of Myeloid Neoplasms with Dysplasia, and a Wide Spectrum of Disease ProgressionWEI CUI; BUESO-RAMOS, Carlos E; CAMERON YIN, C et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 365318.1-365318.7, 4Article

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancyOWEN, Carolyn J; TOZE, Cynthia L; JOHNSON, Peter R. E et al.Blood. 2008, Vol 112, Num 12, pp 4639-4645, issn 0006-4971, 7 p.Article

Polyclonal Immunoglobulin Free Light Chain Levels Predict Survival in Myeloid NeoplasmsPARDANANI, Animesh; LASHO, Terra L; FINKE, Christy M et al.Journal of clinical oncology. 2012, Vol 30, Num 10, pp 1087-1094, issn 0732-183X, 8 p.Article

Isolated del(5q) in myeloid malignancies: Clinicopathologic and molecular features in 143 consecutive patientsPATNAIK, Mrinal M; LASHO, Terra L; FINKE, Christy M et al.American journal of hematology. 2011, Vol 86, Num 5, pp 393-398, issn 0361-8609, 6 p.Article

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignanciesDIEZ-CAMPELO, Maria; PEREZ-SIMON, José Antonio; PEREZ, Jose et al.American journal of hematology. 2009, Vol 84, Num 3, pp 149-152, issn 0361-8609, 4 p.Article

Therapy-related myeloid neoplasms following treatment with radioiodineSCHROEDER, Thomas; KUENDGEN, Andrea; SCHLENK, Richard et al.Haematologica (Roma). 2012, Vol 97, Num 2, pp 206-212, issn 0390-6078, 7 p.Article

Avascular necrosis of the femoral head in childhood chronic myeloid leukaemiaHUGHES, C; PATTERSON, K; MURRAY, M et al.British journal of haematology. 2007, Vol 139, Num 1, issn 0007-1048, 1Article

Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid NeoplasmsNARDI, Valentina; WINKFIELD, Karen M; CHI YOUNG OK et al.Journal of clinical oncology. 2012, Vol 30, Num 19, pp 2340-2347, issn 0732-183X, 8 p.Article

Translational Mini-Review Series on Vaccines : Peptide vaccines for myeloid leukaemiasBARRETT, A. J; REZVANI, K.Clinical and experimental immunology (Print). 2007, Vol 148, Num 2, pp 189-198, issn 0009-9104, 10 p.Article